U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.
Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.
This new pill contains the same active ingredient as injectable Wegovy and Ozempic, semaglutide. It is the first GLP-1 pill ...
The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...
A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for ...
The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug.
In a new clinical trial, people with obesity and knee osteoarthritis who took an experimental drug from Eli Lilly lost large ...
GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight. But they need to be taken for years, ...
After months of rigorous testing and analysis throughout 2025-2026, we are excited to present the most comprehensive review of over-the-counter appetite suppressant supplements specifically formulated ...
The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much ...
But not every claim holds up when you take a deeper look, and not every adaptogen delivers the same benefit. Here’s what the science actually says about some of these compounds and how they affect ...
Drinking Water to Lose Weight: What’s the Idea? You've probably heard many of the ways water is good for you – it helps move waste out of your body, helps your cells work the way they should, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback